On Mar. 26, 2015, Genentech, a member of the Roche Group, announced plans to invest more than $125 million for the expansion of its fill/finish facility in Hillsboro, Oregon. The investment will bring up to 100 new jobs to the state.

Genentech opened operations in Hillsboro in April 2010. The site is home to a state-of-the-art fill/finish facility and warehousing and distribution center. Genentech’s product pipeline is among the strongest in the biotechnology and pharmaceutical industries, and demand for its marketed products continues to grow. The expansion of operations at the Hillsboro site is part of the company’s strategy to increase manufacturing capacity to meet that demand.

Genentech was the first biotechnology company to scale up protein manufacturing successfully from the small quantities used for research to the much larger quantities needed for clinical trials and marketing.